StockrabitBrowse analysts
Analyst questions

Amay Chalke

JM Financial
MANKIND

Mankind Pharma Limited

All company calls
Mankind Pharma Limited CC-Dec23.pdf
2 Feb 2024
Open call
  1. I just had a follow up on the volume and the price constituents. So, basically, going into next year, we will see WPI to be on the lower side, price hike we will get on the NLEM side. So, how do you expect these constituents to change going into next year because the price hi ke component is around 6% right now , your product component is around 4% which I believe is slightly on the higher side compared to peers?

    Read in transcript
  2. Don't you think this price hike strategy is a drift from what we have grown over the last 10 years?

    Read in transcript
  3. In this price hike , is it more towards chronic product, i s it more towards acute p roduct, how would you specify?

    Read in transcript
+3 more questions in this call